Benign lipomatous neoplasm of of intra-abdominal organs

CD2_BENIGN_LIPO_INTRATHO

renal pelvis carcinoma: A carcinoma arising in the renal pelvis. The majority of renal pelvis carcinomas are transitional cell and less frequently squamous cell carcinomas.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D17.5& Cause of death: ICD-10 — D17.5& 2 out of 7 registries used, show all original rules.	114
4. Check minimum number of events None	114
5. Include endpoints None	114
6. Filter based on genotype QC (FinnGen only)	110

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D17
Name in latin: Neoplasma benignum lipomatosum organorum intra-abdominalium

NAME	CD2_BENIGN_LIPO_INTRATHO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D175
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D175
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign lipomatous neoplasm of of intra-abdominal organs based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	625	394	228
Only index persons	590	378	212
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	60.98	60.98	60.94
Only index persons	60.09	60.23	59.85

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	110	66	44
Unadjusted period prevalence (%)	0.02	0.02	0.02
Median age at first event (years)	63.83	61.80	66.88

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
114: Matched controls
1140

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D17.5

ICD-10 Finland

Benign lipomatous neoplasm of intra-abdominal organs

+∞

162.4

114

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

7.1

13.7

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

3.8

9.4

134

A02BC05

ATC

esomeprazole; systemic

2.8

6.7

342

Z2221

NOMESCO Finland

Medical doctor

2.9

6.6

204

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

6.5

6.4

UJF32

NOMESCO Finland

Coloscopy

2.8

6.3

194

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3030467) Casts [#/volume] in Urine by Automated count

262

2.71

6.25

3.2

3.1

1.00

0.51

e6/l

0.35

192

(3011397) Hemoglobin [Presence] in Urine by Test strip

203

2.80

6.20

3.2

3.5

—

(3018095) Leukocytes [#/volume] in Urine

329

2.64

6.10

4.2

3.6

46.95

55.32

e6/l

0.15

230

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

159

2.73

5.33

2.7

1.01

1.07

e6/l

0.05

(36304419) Bacteria [Presence] in Urine

245

2.47

5.03

3.5

2.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

144

2.70

4.93

2.7

2.8

3.24

2.71

e6/l

0.11

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

326

2.33

4.66

3.4

3.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

452

2.33

4.60

4.9

5.2

0.00

estimate

—

(3035350) Ketones [Presence] in Urine by Test strip

455

2.31

4.49

3.3

3.8

0.00

estimate

—

(3002582) Erythrocytes [#/volume] in Urine

283

2.28

4.34

3.5

3.2

23.09

291.55

e6/l

0.59

210

(3009261) Glucose [Presence] in Urine by Test strip

456

2.22

4.12

3.4

3.8

0.00

estimate

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

109

942

4.58

4.06

17.9

14.5

32.36

21.53

mg/l

1.57

745

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

380

2.07

3.57

2.4

2.0

105.21

97.70

pmol/l

0.45

186

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

221

2.16

3.50

2.2

2.1

3.09

3.15

mg/l

0.06

193

(3023368) Bacteria identified in Blood by Culture

262

2.03

3.14

4.2

4.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3.06

3.03

5.8

8.0

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

10.37

3.00

1.4

53.60

77.40

nmol/l

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

164

2.13

2.90

1.3

1.2

6.49

8.65

u/ml

0.12

(3026782) Osmolality of Urine

182

2.05

2.78

3.3

3.4

539.42

531.70

mosm/kgh2o

0.07

152

(3022145) Colonoscopy Study observation

108

2.29

2.74

1.6

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

101

2.32

2.74

2.0

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

6.26

2.73

1.2

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

169

2.05

2.67

1.3

1.2

10.08

38.67

iu/ml

—

(3044889) 12 lead EKG panel

673

1.94

2.50

3.7

4.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

437

1.79

2.39

2.5

—

(3044941) Cell count panel - Synovial fluid

6.47

2.39

1.0

1.4

—

(3012516) Albumin [Mass/volume] in Urine

293

1.82

2.36

3.3

3.2

36.50

46.24

mg/l

0.17

192

(40758558) Short blood count panel - Blood

237

1.83

2.23

6.0

7.8

—

(3000494) Fungus identified in Specimen by Culture

111

2.09

2.19

1.3

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2.29

2.14

2.8

3.4

46.33

62.69

ml/min/173m2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.49

2.14

1.3

1.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

627

1.77

2.10

5.1

4.3

—

478.64

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.20

2.08

1.4

1.5

—

(3003694) ABO and Rh group [Type] in Blood

227

1.78

2.01

1.2

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3.48

2.00

1.0

1.1

—

(3006315) Basophils [#/volume] in Blood

463

1.68

1.98

5.2

0.04

e9/l

0.42

409

(3001604) Monocytes [#/volume] in Blood

463

1.68

1.98

5.2

0.58

0.57

e9/l

0.20

410

(3021788) Differential panel - Synovial fluid

4.70

1.96

1.0

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

644

1.74

1.95

5.0

4.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

438

1.66

1.90

5.3

5.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

529

1.65

1.81

3.1

2.9

—

(40768797) Stomach Pathology biopsy report

135

1.88

1.80

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

120

1.92

1.77

1.7

1.5

—

(1616796) Gas panel - Central venous blood

3.46

1.77

1.8

1.5

—

(4034850) Laboratory test

2.79

1.76

13.6

17.0

—

(3042936) Bacteria identified in Isolate by Culture

136

1.87

1.76

1.7

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

315

1.65

1.74

3.7

3.8

5.62

8.20

mg/mmol

0.29

189

(3002256) Pathology report gross observation

122

1.88

1.69

1.2

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3.27

1.68

1.2

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

108

998

2.56

1.66

11.0

10.9

24.66

24.99

u/l

0.11

108

956

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3.68

1.63

1.0

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.33

1.63

1.3

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

224

1.67

1.58

2.4

2.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

107

989

2.33

1.58

22.4

17.3

79.05

77.78

umol/l

0.15

107

989

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.95

1.57

1.5

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

202

1.66

1.48

1.9

1.8

0.66

1.19

mg/l

1.53

166

(3047181) Lactate [Moles/volume] in Blood

2.60

1.47

3.0

5.1

1.27

1.13

mmol/l

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2.60

1.47

2.3

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

104

1.87

1.47

1.4

1.6

—

(40768804) Tissue Pathology biopsy report

402

1.54

1.44

2.4

2.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

301

1.57

1.42

2.9

3.0

1683.50

1102.08

ng/l

0.41

241

(40761511) CBC panel - Blood by Automated count

106

980

2.16

1.38

15.6

13.9

—

(3044640) Blood type and Crossmatch panel - Blood

303

1.55

1.37

2.5

2.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2.18

1.34

1.4

2.5

—

(3002032) Base excess in Venous blood by calculation

1.88

1.30

3.5

4.0

0.46

2.53

mmol/l

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

545

1.50

1.30

8.1

10.2

4.14

4.15

e9/l

0.01

486

(3016650) Hepatitis A virus Ab [Presence] in Serum

2.86

1.30

1.0

—

(3021589) Normoblasts [#/volume] in Blood

419

1.50

1.29

9.1

10.6

0.00

0.01

e9/l

0.52

344

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

109

1.77

1.28

1.5

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2.31

1.27

1.4

2.3

—

(3016502) Oxygen saturation in Arterial blood

1.82

1.25

5.9

7.9

95.88

96.17

0.12

(3034770) Mitochondria Ab [Titer] in Serum

2.70

1.23

1.2

1.3

—

(3000991) Gas panel - Venous blood

1.91

1.21

6.9

8.5

—

(3012544) pH of Venous blood

1.81

1.18

3.5

4.0

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2.05

1.15

2.6

3.0

23.33

25.02

mmol/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

121

0.47

1.13

6.0

4.8

39.67

32.04

—

(3019309) Folate [Moles/volume] in Red Blood Cells

199

1.54

1.10

1.4

1.7

1195.27

1214.82

nmol/l

0.04

155

(3045414) Leukocytes [Presence] in Urine

2.13

1.05

1.3

2.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

462

1.42

1.03

12.9

14.0

1.41

1.24

inr

0.34

142

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2.29

0.95

1.3

1.1

—

(3049717) Cytology report of Urine Cyto stain

2.20

0.93

1.5

2.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.67

0.93

3.1

2.0

294.60

378.12

nmol/l

0.80

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

454

1.36

0.84

7.1

6.9

1.22

mmol/l

0.03

384

(3008898) HLA-B27 [Presence]

1.92

0.83

1.0

1.1

—

(4035726) Immunohistochemistry procedure

0.48

0.82

1.4

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.86

0.80

1.5

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

160

1.46

0.78

1.5

1.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.81

0.77

1.5

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.81

0.77

1.5

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2.23

0.77

1.0

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1.65

0.75

4.5

2.3

65.13

66.87

g/l

0.44

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.75

0.71

1.7

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1.70

0.71

3.5

8.0

24.45

24.89

mmol/l

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1.70

0.71

2.6

3.0

118.20

129.74

g/l

—

(3026008) Bacteria identified in Urine by Culture

291

1.35

0.71

4.2

3.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

909

1.45

0.67

17.2

14.2

76.00

77.38

ml/min/173m2

0.26

735

(3000330) Specific gravity of Urine by Test strip

1.68

0.63

2.0

5.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.64

0.63

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.64

0.63

1.4

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.58

0.61

2.4

2.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1.58

0.61

3.4

3.7

53.58

43.27

—

(3000492) Spirometry study

1.54

0.60

1.4

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

394

1.28

0.59

4.8

3.8

34.95

34.73

ng/l

0.01

286

(3052851) Hemolysis interference index of Serum or Plasma

1.70

0.57

5.3

3.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

208

1.32

0.54

1.2

0.59

1.71

u/ml

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.54

0.51

1.4

2.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1.52

0.48

2.3

3.7

10.43

241.26

u/ml

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1.49

0.48

2.7

3.3

3.31

0.19

e6/l

—

(40761535) Cells panel - Urine sediment

1.47

0.47

2.2

3.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.46

0.47

2.9

2.5

0.74

0.68

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.43

0.46

8.1

5.8

25.27

24.95

mmol/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

1.59

0.43

3.0

6.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1.59

0.43

2.0

3.5

29.78

32.28

mg/l

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1.59

0.43

1.8

3.5

38.56

52.40

mg/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.41

0.42

1.4

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.41

0.0

1.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

3.8

—

101.04

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.39

0.0

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.39

0.0

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

908

1.28

0.38

3.9

4.3

1.31

1.27

mmol/l

0.26

812

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

144

1.30

0.38

1.6

1.5

—

(4200892) Spirometry reversibility

1.40

0.38

1.3

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.35

0.34

1.0

1.3

—

(40761536) Microorganisms panel - Urine sediment

0.65

0.34

3.7

3.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

356

1.19

0.34

3.7

4.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

194

1.23

0.33

1.3

1.5

2.32

2.91

g/l

0.72

110

(1761868) Lipid panel - Serum or Plasma

342

0.83

0.32

3.7

3.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.40

0.32

2.9

2.5

0.80

1.25

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.37

0.32

1.9

1.3

—

(3025941) Bacteria identified in Stool by Culture

1.24

0.29

2.0

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

236

1.19

0.27

4.3

4.4

21.89

22.29

0.06

108

(3019060) Gas panel - Arterial blood

1.23

0.27

3.9

4.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.72

0.25

2.8

1.9

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1.26

0.22

3.6

5.6

1.56

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.21

0.0

2.7

—

63.80

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(4281824) Cell count and differential, peritoneal fluid

0.00

0.21

0.0

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.21

0.0

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.21

0.0

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.21

0.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.21

0.0

1.3

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.21

0.0

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

112

0.79

0.21

4.2

8.9

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

15.25

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.21

0.0

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.21

0.0

1.2

—

(4146454) Self-monitoring of blood glucose

0.00

0.21

0.0

2.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

3.3

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.21

0.0

2.0

—

31.46

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.20

0.0

1.1

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.20

0.0

2.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

299

0.87

0.20

1.9

2.0

201.52

208.98

u/l

0.03

278

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

131

0.82

0.18

1.3

—

(3022621) pH of Urine by Test strip

0.72

0.17

2.4

2.2

—

(3013512) EKG study

296

0.88

0.17

5.1

4.2

—

(36660697) Celiac disease serology panel - Serum

1.17

0.16

1.2

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.12

0.15

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

257

1.12

0.15

3.7

3.8

0.00

estimate

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.81

0.15

2.6

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

106

0.84

0.13

3.3

3.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

604

0.92

0.13

2.9

3.0

51.05

51.42

u/l

0.01

556

(3003458) Phosphate [Moles/volume] in Serum or Plasma

124

1.15

0.12

9.1

5.0

1.08

1.03

mmol/l

0.35

112

(40768443) Skin Pathology biopsy report

1.17

0.10

1.6

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

0.85

0.08

2.7

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

180

0.93

0.04

3.2

3.0

0.93

0.74

ug/l

—

113

(3018677) aPTT in Platelet poor plasma by Coagulation assay

137

1.02

0.00

2.0

1.9

29.84

29.42

0.10

131

(3012095) Magnesium [Moles/volume] in Serum or Plasma

167

1.02

0.00

5.7

3.3

0.81

mmol/l

0.09

155

(3041096) Erythrocytes [Presence] in Urine by Automated

254

0.98

0.00

3.4

3.7

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

0.0

1.2

—

33.76

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.0

1.0

—

(3004451) EKG impression Narrative

0.00

0.0

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

0.0

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.0

15.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.89

0.00

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.0

3.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

0.0

3.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.0

1.0

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.00

-0.00

0.0

2.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

1.79

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

-0.00

0.0

3.3

—

(3045716) Anion gap in Serum or Plasma

0.00

-0.00

0.0

1.9

—

6.84

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

0.00

-0.00

0.0

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3016018) Differential panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

0.94

-0.00

1.2

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3005033) Fetal Nuchal fold Thickness US

0.00

-0.00

0.0

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

23.2

—

1631.50

—

(21494755) Public health laboratory ask at order entry panel

0.99

-0.00

1.3

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

2.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

0.94

-0.00

3.6

3.2

2.04

2.30

mmol/l

—

(3015183) Erythrocyte sedimentation rate

0.00

-0.00

0.0

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

15.7

—

864.33

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

-0.00

0.0

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

6.59

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

-0.00

0.0

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

-0.00

0.0

1.0

—

(3009343) pH of Capillary blood

0.87

-0.00

4.0

3.0

—

7.45

—

(3017569) Oxygen content in Arterial blood

0.00

-0.00

0.0

12.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

-0.00

0.0

1.4

—

(3011648) Oxygen content in Venous blood

0.00

-0.00

0.0

2.3

—

12.83

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

-0.00

0.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

-0.00

0.0

11.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_LIPO_INTRATHO and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_LIPO_INTRATHO	1.187 [0.88, 1.6]	0.26
Birth year	0.995 [0.99, 1.0]	0.279

During the follow-up period (1.1.1998 — 31.12.2019), 51 out of 322 females with CD2_BENIGN_LIPO_INTRATHO died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_LIPO_INTRATHO.

N-year risk	Females	Males
1	0.124%	No data
5	0.725%	No data
10	1.971%	No data
15	3.655%	No data
20	6.148%	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_LIPO_INTRATHO – Benign lipomatous neoplasm of of intra-abdominal organs

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign lipomatous neoplasm of of intra-abdominal organs

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints